Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Buy
57
CVS Quote, Financials, Valuation and Earnings
Last price:
$78.48
Seasonality move
:
4.15%
Day range:
$77.65 - $79.09
52-week range:
$58.35 - $85.15
Dividend yield:
3.39%
P/E ratio:
56.73x
P/S ratio:
0.25x
P/B ratio:
1.33x
Volume:
6.7M
Avg. volume:
10M
1-year change:
18.25%
Market cap:
$99.8B
Revenue:
$402.1B
EPS (TTM):
$1.38
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CVS
CVS Health Corp.
|
$103.6B | $1.00 | 0.91% | 59% | $94.84 |
|
CI
The Cigna Group
|
$69.1B | $7.88 | 1.33% | 54.67% | $331.31 |
|
HCA
HCA Healthcare, Inc.
|
$19.7B | $7.48 | 4.53% | 11.13% | $530.33 |
|
HUM
Humana, Inc.
|
$32B | -$3.99 | 15.67% | -1.48% | $231.57 |
|
LLY
Eli Lilly & Co.
|
$17.9B | $6.91 | 36.61% | 137.25% | $1,201.63 |
|
PFE
Pfizer Inc.
|
$16.8B | $0.57 | 1.25% | 39.47% | $28.63 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CVS
CVS Health Corp.
|
$78.48 | $94.84 | $99.8B | 56.73x | $0.67 | 3.39% | 0.25x |
|
CI
The Cigna Group
|
$291.44 | $331.31 | $76.8B | 13.14x | $1.51 | 2.07% | 0.36x |
|
HCA
HCA Healthcare, Inc.
|
$540.29 | $530.33 | $120.8B | 19.03x | $0.72 | 0.53% | 1.71x |
|
HUM
Humana, Inc.
|
$184.10 | $231.57 | $22.1B | 18.77x | $0.89 | 1.92% | 0.17x |
|
LLY
Eli Lilly & Co.
|
$1,040.00 | $1,201.63 | $981.1B | 46.04x | $1.73 | 0.6% | 14.54x |
|
PFE
Pfizer Inc.
|
$27.58 | $28.63 | $156.8B | 20.35x | $0.43 | 6.24% | 2.51x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CVS
CVS Health Corp.
|
51.53% | -0.370 | 79.13% | 0.48x |
|
CI
The Cigna Group
|
-- | -1.212 | -- | 0.00x |
|
HCA
HCA Healthcare, Inc.
|
114.13% | 0.062 | 45.04% | 0.73x |
|
HUM
Humana, Inc.
|
41.19% | -0.049 | 40.05% | 0.00x |
|
LLY
Eli Lilly & Co.
|
62.31% | -0.536 | 4.56% | 0.71x |
|
PFE
Pfizer Inc.
|
39.94% | 0.402 | -- | 0.81x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CVS
CVS Health Corp.
|
$13.6B | $2.3B | 1.1% | 2.28% | 2.19% | $2.6B |
|
CI
The Cigna Group
|
-- | $2.6B | 9.38% | 15.18% | -- | $3.1B |
|
HCA
HCA Healthcare, Inc.
|
$3.2B | $3.2B | 17.14% | 3428.29% | 16.29% | $870M |
|
HUM
Humana, Inc.
|
-- | -$808M | 3.96% | 6.77% | -3.11% | -$2.1B |
|
LLY
Eli Lilly & Co.
|
$15.9B | $9B | 34.71% | 104.39% | 46.58% | $254.2M |
|
PFE
Pfizer Inc.
|
$12.3B | $3.7B | 5.07% | 10.84% | 21.01% | $4B |
CVS Health Corp. vs. Competitors
-
Which has Higher Returns CVS or CI?
The Cigna Group has a net margin of 2.77% compared to CVS Health Corp.'s net margin of 8.72%. CVS Health Corp.'s return on equity of 2.28% beat The Cigna Group's return on equity of 15.18%.
Company Gross Margin Earnings Per Share Invested Capital CVSCVS Health Corp.12.82% $2.30 $155.3B CIThe Cigna Group-- $4.64 $41.7B -
What do Analysts Say About CVS or CI?
CVS Health Corp. has a consensus price target of $94.84, signalling upside risk potential of 20.85%. On the other hand The Cigna Group has an analysts' consensus of $331.31 which suggests that it could grow by 13.68%. Given that CVS Health Corp. has higher upside potential than The Cigna Group, analysts believe CVS Health Corp. is more attractive than The Cigna Group.
Company Buy Ratings Hold Ratings Sell Ratings CVSCVS Health Corp.16 5 0 CIThe Cigna Group14 4 0 -
Is CVS or CI More Risky?
CVS Health Corp. has a beta of 0.496, which suggesting that the stock is 50.368% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.271, suggesting its less volatile than the S&P 500 by 72.946%.
-
Which is a Better Dividend Stock CVS or CI?
CVS Health Corp. has a quarterly dividend of $0.67 per share corresponding to a yield of 3.39%. The Cigna Group offers a yield of 2.07% to investors and pays a quarterly dividend of $1.51 per share. CVS Health Corp. pays 191.23% of its earnings as a dividend. The Cigna Group pays out 27.23% of its earnings as a dividend. The Cigna Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CVS Health Corp.'s is not.
-
Which has Better Financial Ratios CVS or CI?
CVS Health Corp. quarterly revenues are $105.7B, which are larger than The Cigna Group quarterly revenues of $14.2B. CVS Health Corp.'s net income of $2.9B is higher than The Cigna Group's net income of $1.2B. Notably, CVS Health Corp.'s price-to-earnings ratio is 56.73x while The Cigna Group's PE ratio is 13.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVS Health Corp. is 0.25x versus 0.36x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CVSCVS Health Corp.0.25x 56.73x $105.7B $2.9B CIThe Cigna Group0.36x 13.14x $14.2B $1.2B
-
Which has Higher Returns CVS or HCA?
HCA Healthcare, Inc. has a net margin of 2.77% compared to CVS Health Corp.'s net margin of 11.09%. CVS Health Corp.'s return on equity of 2.28% beat HCA Healthcare, Inc.'s return on equity of 3428.29%.
Company Gross Margin Earnings Per Share Invested Capital CVSCVS Health Corp.12.82% $2.30 $155.3B HCAHCA Healthcare, Inc.16.29% $8.14 $45.9B -
What do Analysts Say About CVS or HCA?
CVS Health Corp. has a consensus price target of $94.84, signalling upside risk potential of 20.85%. On the other hand HCA Healthcare, Inc. has an analysts' consensus of $530.33 which suggests that it could fall by -1.84%. Given that CVS Health Corp. has higher upside potential than HCA Healthcare, Inc., analysts believe CVS Health Corp. is more attractive than HCA Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CVSCVS Health Corp.16 5 0 HCAHCA Healthcare, Inc.13 8 1 -
Is CVS or HCA More Risky?
CVS Health Corp. has a beta of 0.496, which suggesting that the stock is 50.368% less volatile than S&P 500. In comparison HCA Healthcare, Inc. has a beta of 1.361, suggesting its more volatile than the S&P 500 by 36.136%.
-
Which is a Better Dividend Stock CVS or HCA?
CVS Health Corp. has a quarterly dividend of $0.67 per share corresponding to a yield of 3.39%. HCA Healthcare, Inc. offers a yield of 0.53% to investors and pays a quarterly dividend of $0.72 per share. CVS Health Corp. pays 191.23% of its earnings as a dividend. HCA Healthcare, Inc. pays out 10.17% of its earnings as a dividend. HCA Healthcare, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CVS Health Corp.'s is not.
-
Which has Better Financial Ratios CVS or HCA?
CVS Health Corp. quarterly revenues are $105.7B, which are larger than HCA Healthcare, Inc. quarterly revenues of $19.5B. CVS Health Corp.'s net income of $2.9B is higher than HCA Healthcare, Inc.'s net income of $2.2B. Notably, CVS Health Corp.'s price-to-earnings ratio is 56.73x while HCA Healthcare, Inc.'s PE ratio is 19.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVS Health Corp. is 0.25x versus 1.71x for HCA Healthcare, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CVSCVS Health Corp.0.25x 56.73x $105.7B $2.9B HCAHCA Healthcare, Inc.1.71x 19.03x $19.5B $2.2B
-
Which has Higher Returns CVS or HUM?
Humana, Inc. has a net margin of 2.77% compared to CVS Health Corp.'s net margin of -2.39%. CVS Health Corp.'s return on equity of 2.28% beat Humana, Inc.'s return on equity of 6.77%.
Company Gross Margin Earnings Per Share Invested Capital CVSCVS Health Corp.12.82% $2.30 $155.3B HUMHumana, Inc.-- -$6.61 $30.1B -
What do Analysts Say About CVS or HUM?
CVS Health Corp. has a consensus price target of $94.84, signalling upside risk potential of 20.85%. On the other hand Humana, Inc. has an analysts' consensus of $231.57 which suggests that it could grow by 25.78%. Given that Humana, Inc. has higher upside potential than CVS Health Corp., analysts believe Humana, Inc. is more attractive than CVS Health Corp..
Company Buy Ratings Hold Ratings Sell Ratings CVSCVS Health Corp.16 5 0 HUMHumana, Inc.6 17 2 -
Is CVS or HUM More Risky?
CVS Health Corp. has a beta of 0.496, which suggesting that the stock is 50.368% less volatile than S&P 500. In comparison Humana, Inc. has a beta of 0.437, suggesting its less volatile than the S&P 500 by 56.287%.
-
Which is a Better Dividend Stock CVS or HUM?
CVS Health Corp. has a quarterly dividend of $0.67 per share corresponding to a yield of 3.39%. Humana, Inc. offers a yield of 1.92% to investors and pays a quarterly dividend of $0.89 per share. CVS Health Corp. pays 191.23% of its earnings as a dividend. Humana, Inc. pays out 35.98% of its earnings as a dividend. Humana, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CVS Health Corp.'s is not.
-
Which has Better Financial Ratios CVS or HUM?
CVS Health Corp. quarterly revenues are $105.7B, which are larger than Humana, Inc. quarterly revenues of $32.5B. CVS Health Corp.'s net income of $2.9B is higher than Humana, Inc.'s net income of -$776M. Notably, CVS Health Corp.'s price-to-earnings ratio is 56.73x while Humana, Inc.'s PE ratio is 18.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVS Health Corp. is 0.25x versus 0.17x for Humana, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CVSCVS Health Corp.0.25x 56.73x $105.7B $2.9B HUMHumana, Inc.0.17x 18.77x $32.5B -$776M
-
Which has Higher Returns CVS or LLY?
Eli Lilly & Co. has a net margin of 2.77% compared to CVS Health Corp.'s net margin of 34.4%. CVS Health Corp.'s return on equity of 2.28% beat Eli Lilly & Co.'s return on equity of 104.39%.
Company Gross Margin Earnings Per Share Invested Capital CVSCVS Health Corp.12.82% $2.30 $155.3B LLYEli Lilly & Co.82.52% $7.02 $70.4B -
What do Analysts Say About CVS or LLY?
CVS Health Corp. has a consensus price target of $94.84, signalling upside risk potential of 20.85%. On the other hand Eli Lilly & Co. has an analysts' consensus of $1,201.63 which suggests that it could grow by 15.54%. Given that CVS Health Corp. has higher upside potential than Eli Lilly & Co., analysts believe CVS Health Corp. is more attractive than Eli Lilly & Co..
Company Buy Ratings Hold Ratings Sell Ratings CVSCVS Health Corp.16 5 0 LLYEli Lilly & Co.18 6 0 -
Is CVS or LLY More Risky?
CVS Health Corp. has a beta of 0.496, which suggesting that the stock is 50.368% less volatile than S&P 500. In comparison Eli Lilly & Co. has a beta of 0.388, suggesting its less volatile than the S&P 500 by 61.171%.
-
Which is a Better Dividend Stock CVS or LLY?
CVS Health Corp. has a quarterly dividend of $0.67 per share corresponding to a yield of 3.39%. Eli Lilly & Co. offers a yield of 0.6% to investors and pays a quarterly dividend of $1.73 per share. CVS Health Corp. pays 191.23% of its earnings as a dividend. Eli Lilly & Co. pays out 26.14% of its earnings as a dividend. Eli Lilly & Co.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CVS Health Corp.'s is not.
-
Which has Better Financial Ratios CVS or LLY?
CVS Health Corp. quarterly revenues are $105.7B, which are larger than Eli Lilly & Co. quarterly revenues of $19.3B. CVS Health Corp.'s net income of $2.9B is lower than Eli Lilly & Co.'s net income of $6.6B. Notably, CVS Health Corp.'s price-to-earnings ratio is 56.73x while Eli Lilly & Co.'s PE ratio is 46.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVS Health Corp. is 0.25x versus 14.54x for Eli Lilly & Co.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CVSCVS Health Corp.0.25x 56.73x $105.7B $2.9B LLYEli Lilly & Co.14.54x 46.04x $19.3B $6.6B
-
Which has Higher Returns CVS or PFE?
Pfizer Inc. has a net margin of 2.77% compared to CVS Health Corp.'s net margin of -9.34%. CVS Health Corp.'s return on equity of 2.28% beat Pfizer Inc.'s return on equity of 10.84%.
Company Gross Margin Earnings Per Share Invested Capital CVSCVS Health Corp.12.82% $2.30 $155.3B PFEPfizer Inc.69.97% -$0.29 $154.8B -
What do Analysts Say About CVS or PFE?
CVS Health Corp. has a consensus price target of $94.84, signalling upside risk potential of 20.85%. On the other hand Pfizer Inc. has an analysts' consensus of $28.63 which suggests that it could grow by 3.8%. Given that CVS Health Corp. has higher upside potential than Pfizer Inc., analysts believe CVS Health Corp. is more attractive than Pfizer Inc..
Company Buy Ratings Hold Ratings Sell Ratings CVSCVS Health Corp.16 5 0 PFEPfizer Inc.7 16 1 -
Is CVS or PFE More Risky?
CVS Health Corp. has a beta of 0.496, which suggesting that the stock is 50.368% less volatile than S&P 500. In comparison Pfizer Inc. has a beta of 0.472, suggesting its less volatile than the S&P 500 by 52.751%.
-
Which is a Better Dividend Stock CVS or PFE?
CVS Health Corp. has a quarterly dividend of $0.67 per share corresponding to a yield of 3.39%. Pfizer Inc. offers a yield of 6.24% to investors and pays a quarterly dividend of $0.43 per share. CVS Health Corp. pays 191.23% of its earnings as a dividend. Pfizer Inc. pays out 126.47% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CVS or PFE?
CVS Health Corp. quarterly revenues are $105.7B, which are larger than Pfizer Inc. quarterly revenues of $17.6B. CVS Health Corp.'s net income of $2.9B is higher than Pfizer Inc.'s net income of -$1.6B. Notably, CVS Health Corp.'s price-to-earnings ratio is 56.73x while Pfizer Inc.'s PE ratio is 20.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVS Health Corp. is 0.25x versus 2.51x for Pfizer Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CVSCVS Health Corp.0.25x 56.73x $105.7B $2.9B PFEPfizer Inc.2.51x 20.35x $17.6B -$1.6B
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Is Sandisk The Next Big Memory Stock?
Computer memory manufacturer Sandisk (NASDAQ:SNDK) has quietly been one of…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
